Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

A report of a trial stated that there was "growing evidence that chronic hepatitis was a not-uncommon consequence of transfusion", related to the total number of donors to whose blood a patient had been exposed.

  • Read more about A report of a trial stated that there was "growing evidence that chronic hepatitis was a not-uncommon consequence of transfusion", related to the total number of donors to whose blood a patient had been exposed.

There was a trial to see which of three dosage regimes addressed bleeds into knee, elbow and ankle joints most effectively. This involved pupils being given doses of 7, 14, or 28 units (per kilogram of their bodyweight), and was written up in The Lancet.

  • Read more about There was a trial to see which of three dosage regimes addressed bleeds into knee, elbow and ankle joints most effectively. This involved pupils being given doses of 7, 14, or 28 units (per kilogram of their bodyweight), and was written up in The Lancet.

Dr Craske encouraged further research and applied for a research grant on hepatitis associated with the use of commercial Factor 8.

  • Read more about Dr Craske encouraged further research and applied for a research grant on hepatitis associated with the use of commercial Factor 8.

Dr Craske from the Public Health Laboratory Service encouraged further study of hepatitis associated with the use of commercial Factor 8.

  • Read more about Dr Craske from the Public Health Laboratory Service encouraged further study of hepatitis associated with the use of commercial Factor 8.

Dr Kirk proposed to restrict patients to either commercial concentrates as a group or cryoprecipitate or Lister Concentrate as part of the next stage of a hepatitis study.

  • Read more about Dr Kirk proposed to restrict patients to either commercial concentrates as a group or cryoprecipitate or Lister Concentrate as part of the next stage of a hepatitis study.

A letter about a Treloar's pupil written to his home clinician showed that there had been no advance discussion about the research on him.

  • Read more about A letter about a Treloar's pupil written to his home clinician showed that there had been no advance discussion about the research on him.

Dr Kirk wrote to parents of a student at Treloar's to inform them their son had been "selected to receive only Kryobulin when he requires transfusing. By limiting him to this type of factor VIII containing material it will be easier to trace the source should he contract hepatitis."

  • Read more about Dr Kirk wrote to parents of a student at Treloar's to inform them their son had been "selected to receive only Kryobulin when he requires transfusing. By limiting him to this type of factor VIII containing material it will be easier to trace the source should he contract hepatitis."

Hemofil was given to one child as part of the study; he did not bleed frequently and so needed only limited treatment, but went on to develop acute hepatitis.

  • Read more about Hemofil was given to one child as part of the study; he did not bleed frequently and so needed only limited treatment, but went on to develop acute hepatitis.

It was acknowledged that recent research had shown that viruses other than Hepatitis A and B may have caused significant amount of post-transfusion hepatitis.

  • Read more about It was acknowledged that recent research had shown that viruses other than Hepatitis A and B may have caused significant amount of post-transfusion hepatitis.

From 1970 to 1973, Dr Rainsford studied the incidence of serum hepatitis. The aim was to see if there was any pattern to the way in which antibodies and antigens to serum hepatitis correlated with clinical illness, the frequency of transfusion and the presence of antigens in the blood products with which they were being treated.

  • Read more about From 1970 to 1973, Dr Rainsford studied the incidence of serum hepatitis. The aim was to see if there was any pattern to the way in which antibodies and antigens to serum hepatitis correlated with clinical illness, the frequency of transfusion and the presence of antigens in the blood products with which they were being treated.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 827
  • Page 828
  • Page 829
  • Page 830
  • Current page 831
  • Page 832
  • Page 833
  • Page 834
  • Page 835
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.